Medidata CTMS to support QCTR clinical operations
Medidata CTMS is expected to help in the reduction of time and effort that is required for tracking key milestones and operational metrics throughout their clinical studies and
BioMarin Pharmaceutical and n-Lorem Foundation have entered an early-stage research collaboration and exclusive global licence agreement to develop an investigational antisense oligonucleotide (ASO) therapy for ReNU syndrome.